Evaxion A (EVAX) Non-Current Deferred Tax Liability (2022 - 2025)

Evaxion A (EVAX) reported Non-Current Deferred Tax Liability of $156000.0 for Q4 2025, up 19.08% on a YoY basis from $131000.0 in Q4 2024, and up 19.08% quarter-over-quarter from $131000.0 in Q4 2024.

Evaxion A (EVAX) Non-Current Deferred Tax Liability (2022 - 2025) Analysis & Trends

Evaxion A has reported Non-Current Deferred Tax Liability for 4 years, with the latest figure at $156000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Deferred Tax Liability rose 19.08% year-over-year to $156000.0; the trailing twelve-month figure through Dec 2025 stood at $156000.0 (up 19.08% YoY), and the FY2025 full-year result was $156000.0, up 19.08% from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 stood at $156000.0, up from $131000.0 in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $214000.0 in Q4 2022, with the low at $126000.0 in Q4 2023.
  • Historically, Non-Current Deferred Tax Liability has averaged $156750.0 across 4 years, with a median of $143500.0 in 2024.
  • Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability slumped 41.12% — and 2025, when it climbed 19.08%.
  • Evaxion A's Non-Current Deferred Tax Liability stood at $214000.0 in 2022, then slumped by 41.12% to $126000.0 in 2023, then advanced by 3.97% to $131000.0 in 2024, then rose by 19.08% to $156000.0 in 2025.
  • The last three Non-Current Deferred Tax Liability figures came in at $156000.0 (Q4 2025), $131000.0 (Q4 2024), and $126000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 156,000.00
Dec 31, 2025 156,000.00
Dec 31, 2024 131,000.00
Dec 31, 2024 131,000.00
Dec 31, 2023 126,000.00
Dec 31, 2023 126,000.00
Dec 31, 2022 214,000.00
Dec 31, 2022 214,000.00